Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-02

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approves an original generic application for a fixed-dose combination tablet of amlodipine and olmesartan medoxomil by Micro Labs Limited for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

ORIG AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)